| Net Cash Provided by (Used in) Operating Activities |
-1.4M |
USD |
-2466% |
Q1 2025 |
Q1 2025 |
| Net Cash Provided by (Used in) Financing Activities |
0 |
USD |
-100% |
Q1 2025 |
Q1 2025 |
| Net Cash Provided by (Used in) Investing Activities |
1.4M |
USD |
|
Q1 2025 |
Q1 2025 |
| Common Stock, Shares Authorized |
20B |
shares |
|
Q2 2025 |
Q2 2025 |
| Common Stock, Shares, Issued |
7.38M |
shares |
|
Q2 2025 |
Q2 2025 |
| Common Stock, Par or Stated Value Per Share |
0 |
USD/shares |
|
Q2 2025 |
Q2 2025 |
| Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect |
-1.04K |
USD |
-400% |
Q1 2025 |
Q1 2025 |
| Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents |
1.68K |
USD |
-84.8% |
Q2 2025 |
Q2 2025 |
| Deferred Tax Assets, Valuation Allowance |
2.82M |
USD |
+18.6% |
Q4 2024 |
FY 2024 |
| Depreciation |
9.36K |
USD |
0% |
Q1 2025 |
Q1 2025 |
| Property, Plant and Equipment, Gross |
223K |
USD |
|
Q2 2025 |
Q2 2025 |
| Preferred Stock, Shares Issued |
500M |
shares |
|
Q2 2025 |
Q2 2025 |
| Preferred Stock, Shares Authorized |
500M |
shares |
|
Q2 2025 |
Q2 2025 |
| Additional Paid in Capital |
2.31M |
USD |
|
Q2 2025 |
Q2 2025 |
| Deferred Tax Assets, Net of Valuation Allowance |
0 |
USD |
|
Q4 2024 |
FY 2024 |
| Interest Expense |
0 |
USD |
-100% |
Q2 2025 |
Q2 2025 |
| Preferred Stock, Par or Stated Value Per Share |
0 |
USD/shares |
|
Q2 2025 |
Q2 2025 |